Anticholinergic agents for chronic asthma in adults

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 7, 2004, Pages

  Westby, Maggie J ^a   Benson, Malcolm K ^b   Gibson, Peter G ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c JOHN HUNTER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE METHYL NITRATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; GLYCOPYRRONIUM; IPRATROPIUM BROMIDE; OXITROPIUM BROMIDE; PLACEBO; TIOTROPIUM BROMIDE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ANTICHOLINERGIC EFFECT; ANXIETY DISORDER; ASTHMA; BRONCHODILATATION; CLINICAL PRACTICE; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG QUALITY; DRUG SAFETY; FLOW MEASUREMENT; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GASTROINTESTINAL IRRITATION; GENERAL PRACTICE; HEADACHE; HEART PALPITATION; HUMAN; OUTCOME ASSESSMENT; PATIENT PREFERENCE; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUASI EXPERIMENTAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SOMNOLENCE; STOMACH IRRITATION; SYSTEMATIC REVIEW; TACHYCARDIA; TASTE DISORDER; TREATMENT DURATION; TREATMENT RESPONSE; TREMOR; XEROSTOMIA; ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC BETA-AGONISTS; ADULT; ASTHMA; CHOLINERGIC ANTAGONISTS; DRUG THERAPY, COMBINATION; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 16544387930     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD003269.pub2     Document Type: Review

References (288)

1. Ahonen A, Alanko K, Mattson K. Bronchodilator action of two different doses of ipratropium bromide (SCH 1000) compared with fenoterol and placebo. Current therapeutic research, clinical and experimental. 1978;24:65. 3129405
2. Ashutosh K, Mead G, Dickey JC Jr, Berman P, Kuppinger M. Density dependence of expiratory flow and bronchodilator response in asthma. Chest 1980;77:68. 3129407
3. Bellia V, Ferrara G, Cibella F, Cuttitta G, Visconti A, Insalaco G, et al. Comparison of the effect of oxitropium bromide and of slow-release theophylline on nocturnal asthma. Postgraduate Medical Journal 1988;64:583. 3129409
4. Chapman KR, Rebuck AS. Anticholinergic and sympathomimetic combination therapy of asthma. Annals of allergy 1983;50:350. 3129411
5. Coe CI, Barnes PJ. Reduction of nocturnal asthma by an inhaled anticholinergic drug. Chest 1986;90:485. 3129413
6. Dompeling E, van Schayck CP, Molema J, Folgering H, van Grunsven PM, van Weel C. Inhaled beclomethasone improves the course of asthma and COPD. European Respiratory Journal 1992;5:945. 3129415
7. Dompeling E, van Schayck C, van Grunsven P, et al. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled. Annals of Internal Medicine 1993;118:770. 3129417
8. Haahtela T, Ahokas I, Ahonen A, van Assendelft A, Havu M, Havu K, et al. Inhaled bronchodilator's in asthma: low or high dose?. Annals of Allergy 1991;66:175. 3129419
9. Kreisman H, Frank H, Wolkove N, Gent M. Synergism between ipratropium and theophylline in asthma. Thorax 1981;36:387. 3129421
10. Laitinen LA, Poppius H, Haahtela T. Comparison of ipratropium bromide and salbutamol in a long-term trial in asthmatic and bronchitis patients in a cold climate. Scandinavian Journal of Respiratory Diseases-Supplementum 1979;103:163-9. 3129423
11. Light RW, George RB. Oral atropine in the treatment of chronic asthma. Annals of allergy 1977;38(1):58-61. 3129425
12. Lightbody I, Ingram C, Legge JS, Johnston RN. Ipratropium bromide, salbutamol, and prednisolone in bronchial asthma and chronic bronchitis. Thorax 1977;32:645. 3129427
13. Lightbody IM, Ingram CG, Legge JS, Johnston RN. Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitis. British Journal of Diseases of the Chest 1978;72:181. 3129429
14. Macaluso S, del Torre L. Efficacy and compliance to prolonged treatment of bronchospasm. Respiration 1986;50(Suppl 2):222-5. 3129431
15. Mazzei JA, Torres J. Blind randomized cross-over comparative study of salbutamol and the combination fenoterol-ipratropium IK6 in patients with bronchial asthma. Respiration 1986;50(Suppl 2):313. 3129433
16. Mazzei JA, Torres J. Comparative randomized blind cross over study between salbutamol and the fenoterol-ipratropium association (IK 6) in patients with bronchial asthma. Prensa medica Argentina 1985;72:329. 3129434
17. O'Driscoll BR, Kay EA, Taylor RJ, Bernstein A. Home nebulizers: can optimal therapy be predicted by laboratory studies?. Respiratory Medicine 1990;84:471. 3129436
18. O'Driscoll BR, Kay EA, Taylor RJ, Weatherby H, Chetty MC, Bernstein A. A long-term prospective assessment of home nebulizer treatment. Respiratory Medicine 1992;86:317. 3129438
19. Pavia D, Lopez-Vidriero MT, Agnew JE, Taylor RG, Eyre-Brook A, Lawton WA, et al. Effect of four weeks' oxitropium bromide treatment on lung mucociliary clearance in patients with chronic bronchitis or asthma. Postgraduate Medical Journal 1987;63(Suppl 1):15a. 3129440
20. Pavia D, Lopez-Vidriero MT, Agnew JE, Taylor RG, Eyre-Brook A, Lawton WA, et al. Effect of four-week treatment with oxitropium bromide on lung mucociliary clearance in patients with chronic bronchitis or asthma. Respiration 1989;55:33. 3129442
21. Petersen BN, Weeke E. A comparative study of the bronchodilatating effects of ipratropium and terbutalin inhaled with Monaghan IPPB-M 515 by 19 patients with chronic asthma. Scandinavian Journal of Respiratory Diseases 1979;103:178. 3129444
22. Philip-Joet F, Reynaud-Gaubert M, Jirou-Najou JL, Arnaud A. Comparison of Berodual and salbutamol in asthma: a multicenter evaluation. Respiration 1990;57:379. 3129446
23. Pierce RJ Holmes PW Campbell AH. Use of ipratropium bromide in patients with severe airways obstruction. Australian and New Zealand journal of medicine 1982;12:38. 3129448
24. Rebuck AS, Gent M, Chapman KR. Anticholinergic and sympathomimetic combination therapy of asthma. The Journal of Allergy and Clinical Immunology 1983;71(3):317-23. 3129450
25. Ruffin R, Blight M. Effect of inhaled oxitropium bromide in asthmatics. Australian and New Zealand Journal of Medicine 1990;20:525. 3129452
26. Salorinne Y, Ahonen A. Comparison of the bronchodilator effect of ipratropium bromide powder and two doses of ipratropium bromide aerosol in the treatment of asthma. Current therapeutic research, clinical and experimental. 1988;43(6):1073-80. 3129454
27. Storms WW, Bodman SF, Nathan RA, Busse WW, Bush RK, Falliers CJ, O'Hollaren JD, et al. Use of ipratropium bromide in asthma Results of a multi-clinic study. The American Journal of Medicine 1986;81:61. 3129456
28. Tammivaara R, Elo J, Mansury L. Terbutaline controlled-release tablets and ipratropium aerosol in nocturnal asthma. Allergy 1993;48:45. 3129458
29. Taylor RG, Pavia D, Agnew J, Lopez-Vidriero M, Newman S, Lennard-Jones T, Clarke S. Effect of four weeks' high dose ipratropium bromide treatment on lung mucociliary clearance. Thorax 1986;41:295. 3129460
30. Taytard A, Auzerie J, Vergeret J, Tozon N, Freour P. Treatment of adult asthma: controlled double-blind clinical trial of oxitropium bromide. European Journal of Clinical Pharmacology 1984;26:429. 3129462
31. Tormey VJ, Pathmakanthan S, Faul J, Leonard C, Poulter LW, Burke CM. A comparison of the effects of inhaled salbutamol or oxitropium bromide on bronchial hyperresponsiveness in asthmatic patients treated with. Irish Journal of Medical Science 1995;164:172. 3129464
32. van Schayck CP, Dompeling E, van Herwaarden CL, Folgering H, Verbeek AL, van der Hoogen HJ, et al. Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study. BMJ 1991;303:1426. 3129466
33. van Schayck CP, Folgering H, Harbers H, Maas KL, van Weel C. Effects of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis. Thorax 1991;46:355. 3129468
34. van Schayck CP, Folgering H, den Otter JJ, Tirimanna P, van Weel C. Does continuous use of bronchodilators disguise the progression of chronic nonspecific lung diseases?. Tijdschrift voor geneeskunde 1994;50:787. 3129470
35. van Schayck CP, Dompeling E, van Herwaarden CL, Folgering H, Akkermans RP, van den Broek PJ, et al. Continuous and on demand use of bronchodilators in patients with non-steroid dependent asthma and chronic bronchitis: four-year follow-up randomized controlled study. British Journal of General Practice 1995;45:239. 3129472
36. Vaughan TR, Bowen RE, Goodman DL, Weber RW, Nelson HS. The development of subsensitivity to atropine methylnitrate A double-blind, placebo-controlled crossover study. The American Review of Respiratory Disease 1988;138:771. 3129474
37. Waite DA. Comparison of Duovent with salbutamol in chronic asthmatics - a long term study in community practice. Postgraduate Medical Journal 1987;63(Suppl 1):4a. 3129476
38. Wheeler AW, Guest PG, Britton MG. A three month study of oxitropium bromide in patients with bronchial asthma. Postgraduate Medical Journal 1987;63:8. 3129478
39. Wolstenholme RJ, Shettar SP. Comparison of a combination of fenoterol with ipratropium bromide (Duovent) and salbutamol in young adults with nocturnal asthma. Respiration 1989;55:152. 3129480
40. Abboud R, Gibson N, Vickerson F, Mukherjee J. Bronchodilating effect of increasing doses of fenoterol (Berotec) given in combination with a standard dose of ipratropium (Atrovent) in asthma. Postgraduate Medical Journal 1987;63(Suppl 1):5. 3129482
41. Adinoff AD, Schwartz HJ, Rickard KA, Yancey SW, Swearingen BE. Salmeterol compared with current therapies in chronic asthma. Journal of Family Practice 1998;47:278. 3129484
42. Advenier C, Cerrina J, Duroux P. Bronchodilators. Semaine Des Hopitaux 1984;60:179. 3129486
43. Alanko K, Sahlstrom K, Harkonen R. Combination of fenoterol and ipratropium bromide in the treatment of bronchial asthma. European Journal of Respiratory Diseases-Supplement 1983;128(Pt 2):546. 3129488
44. Allen CJ, Campbell AH. Comparison of inhaled atropine sulphate and atropine methonitrate. Thorax 1980;35:932. 3129490
45. Allen CJ, Campbell AH. Dose response of ipratropium bromide assessed by two methods. Thorax 1980;35:137. 3129492
46. Alliott RJ, Lang BD, Rawson DR, Leckie WJ. Effects of salbutamol and isoprenaline-phenylephrine in reversible airways obstruction. BMJ 1972;1:539. 3129494
47. Altounyan RE. Variation of drug action on airway obstruction in man. Thorax 1964;19:406. 3129496
48. Andersen L. Pulmonary function and acid application in the esophagus. Chest 1986;90:358. 3129498
49. Anderson G, Jariwalla AG, Turnbull P. The effects of fenoterol, ipratropium bromide and their combination in asthma and chronic bronchitis. British Journal of Diseases of the Chest 1980;74:416. 3129500
50. Anderson G, Jariwalla AG, Turnbull P, Veale J. The effects of fenoterol, ipratroprium bromide and their combination in asthma and chronic bronchitis. IRCS (International Research Communications System) Medical Science 1981;9:251. 3129502
51. Anderson G. Anticholinergic drugs in airways obstruction. Postgraduate Medical Journal 1983;59(Suppl 3):64. 3129504
52. Aquilina R, Bergero F, Noceti P, Mirabelli S, Luciani G. Protective effect of Duovent versus salbutamol in long-term treatment. Respiration 1986;50(Suppl 2):240. 3129506
53. Ariano R, Giacca S. Variations of individual susceptibility to beta-adrenergic and anticholinergic bronchodilator drugs. Minerva Pneumologica 1981;20:141. 3129508
54. Baigelman W, Chodosh S. Bronchodilator action of the anticholinergic drug, ipratropium bromide (Sch 1000), as an aerosol in chronic bronchitis and asthma. Chest 1977;71:324. 3129510
55. Banos Hidalgo P, Ramos Martos A, Cabrera Moreno R, Luque Leal J, Palacios Giner A. Comparative double blind study of the aerosol association of ipratropium bromide and salbutamol with its individual effect in chronic bronchitis. Revista Clinica Espanola 1983;171:265. 3129512
56. Barber P, Chatterjee SS, Scott R. The effect of two anticholinergic bronchodilators on ventilatory function in patients with chronic bronchitis or asthma as measured by spirometry. Postgraduate Medical Journal 1975;51(Suppl):112. 3129514
57. Barber PV, Chatterjee SS, Scott R. A comparison of ipratropium bromide, deptropine citrate and placebo in asthma and chronic bronchitis. British Journal of Diseases of the Chest 1977;71:101. 3129516
58. Bauer P, Kummer F. Double-blind study for the comparison of the broncholytic effect of a new tropic acid derivative with isoprenaline. International Journal of Clinical Pharmacology and Therapeutics 1973;8:135. 3129518
59. Beasley CR, Rafferty P, Holgate ST. Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution. BMJ 1987;294:1197. 3129520
60. Bell R, Sahay JN, Barber PV, Chatterjee SS, Cox G. A therapeutic comparison of ipratropium bromide and salbutamol in asthmatic patients. Current Medical Research & Opinion 1982;8:242. 3129522
61. Bellia V, Cibella F, Insalaco G, Mirto M, Peralta G, Visconti A, Schiassi M. Comparison of the effectiveness of oxitropium bromide and of a slow-release theophylline in the prevention of 'morning dip' in asthmatics. Postgraduate Medical Journal 1987;63:9. 3129524
62. Bernabeu L, Bourcereau J, Delacenserie R, Prosper M, Salen JM, Vincent J, Jirou-Najou JL. Ipratropium bromide -fenoterol combination: optimum dosage ratio in asthma. Postgraduate Medical Journal 1987;63(Suppl 1):6. 3129526
63. Bezel R, Brandli O, Braun P, Haegi V, Villiger B. Additive effect of sustained-release theophylline combined with anticholinergic and sympathomimetic therapy in COPD. Postgraduate Medical Journal 1987;63(Suppl 1):22. 3129528
64. Bish R, Thien F, Whitehead F, Walters J, Walters EH. The use of regular ipratropium bromide to reduce requirements for beta-2 agonists in symptomatic asthmatic subjects [abstract]. Australian and New Zealand Journal of Medicine 1997;27:246. 3129530
65. Bohadana AB, Peslin R, Teculescu D, Polu JM, et al. The bronchodilator action of theophylline aerosol in subjects with chronic airflow obstruction. Clinical Respiratory Physiology 1980;16:13. 3129532
66. Bonsignore G, Bellia V, Peralta G, Alessi N, Migliara G. The combination of fenoterol and ipratropium bromide in bronchial asthma: comparison of the acute effects of two different dosages. Respiration 1986;50(Suppl 2):148. 3129534
67. Botts LD, Pingleton SK, Schroeder CE, Robinson RG, Hurwitz A. Prolongation of gastric emptying by aerosolized atropine. The American Review of Respiratory Disease 1985;131:725. 3129536
68. Brady RE, Easton JG. The value of atropine in the documentation of reversible airways obstruction. Annals of Allergy 1979;42:211. 3129538
69. Brand PL, Kerstjens HA, Postma DS, Sterk PJ, Quanjer PH, Sluiter HJ, et al. Long-term multicentre trial in chronic nonspecific lung disease: methodology and baseline assessment in adult patients Dutch CNSLD Study Group. European Respiratory Journal 1992;5:21. 3129540
70. Bremner P, Burgess C, Beasley R, Woodman K, Marshall S, Crane J, Pearce N. Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics. Respiratory Medicine 1992;86:419. 3129542
71. Britton J, Hanley SP, Garrett HV, Hadfield JW, Tattersfield AE. Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma. Thorax 1988;43:300. 3129544
72. Brom AL. Prophylaxis of bronchial asthma in adults with the use of ketotifen: Prolongation of gastric emptying by aerosolized atropine. The American review of respiratory disease 1985;8:725. 3129546
73. Bruderman I, Cohen-Aronovski R, Smorzik J. A comparative study of various combinations of ipratropium bromide and metaproterenol in allergic asthmatic patients. Chest 1983;83:208. 3129548
74. Brumby KH. Comparative clinical study of the efficacy of Atrovent and Berotec, singly and combined, with comparison of placebo. Therapiewoche 1980;30:2796. 3129550
75. Bryant DH Rogers P. Oxitropium bromide: an acute dose response study of a new anticholinergic drug in combination with fenoterol in asthma and chronic bronchitis. Pulmonary Pharmacology 1990;3:55. 3129552
76. Bryant D, Rogers P. Comparison of preservative-free ipratropium bromide and atrovent nebuliser solution in treatment of asthma [abstract]. Australian and New Zealand Journal of Medicine 1990;20:525. 3129554
77. Bryant DH, Rogers P. Effects of ipratropium bromide nebulizer solution with and without preservatives in the treatment of acute and stable asthma. Chest 1992;102:742. 3129556
78. Burge PS, Harries MG, l'Anson E. Comparison of atropine with ipratropium bromide in patients with reversible airways obstruction unresponsive to salbutamol. British Journal of Diseases of the Chest 1980;74:259. 3129558
79. Burki NK. The effects of the combination of inhaled ipratropium and oral theophylline in asthma. Chest 1997;111:1509. 3129560
80. Cañete CE. Treatment with anticholinergic drugs in asthmatic crisis. Archivos De Bronconeumología Suppl 1991;27:32. 3129572
81. Capel LH, Fletcher EC. Spirometric integrals after isoprenaline and atropine in asthma. British Journal of Diseases of the Chest 1964;58:174. 3129562
82. Carpentiere G, Marino S, Castello F, Bonanno CT. Comparison between morning and afternoon effects of inhaling a combined preparation of fenoterol with ipratropium bromide. Current Therapeutic Research 1986;40:265. 3129564
83. Carratu L, Sofia M. Comparison of the effects of inhalation of a single dose of a ipratropium bromide-fenoterol combination with a single dose of fenoterol. Archivio Monaldi Per La Tisiologia e Le Malattie Dell Apparato Respiratorio 1983;38:263. 3129566
84. Casali L, Grassi C, Rampulla C, Rossi A. Clinical pharmacology of a combination of bronchodilators. International Journal of Clinical Pharmacology and Biopharmacy 1979;17:277. 3129568
85. Catterall JR, Rhind GB, Whyte KF, Shapiro CM, Douglas NJ. Is nocturnal asthma caused by changes in airway cholinergic activity?. Thorax 1988;43:720. 3129570
86. Chakravarti A, Pratley M, Barcharb J, Musiosky M, McDonald F, Vickerson F, et al. Ipratropium-fenoterol interaction study in asthmatic adults. Postgraduate Medical Journal 1987;63(Suppl 1):5. 3129574
87. Chervinsky P. Double-blind study of ipratropium bromide, a new anticholinergic bronchodilator. Journal of Allergy and Clinical Immunology 1977;59:22. 3129576
88. Chhabra SK, Pandey KK. Comparison of acute bronchodilator effects of inhaled ipratropium bromide and salbutamol in bronchial asthma. Journal of Asthma 2002;39:375. 3129578
89. Chick TW, Jenne JW. Comparative bronchodilator responses to atropine and terbutaline in asthma and chronic bronchitis. Chest 1977;72:719. 3129580
90. Chuchalin AG, Konganova NA, Pashkova TL, Treskunov VK, Apul'tsina ID. Berodual in the treatment of bronchial asthma. Sovetskaia Meditsina 1985;11:81. 3129582
91. Ciappi G, Magnini P, Valente S, Toscano L, Corbo GM, Culla G, Patalano F. Dose-response relationship: fenoterol, ipratropium bromide and their combination. Respiration 1986;50(Suppl 2):140. 3129584
92. Clauzel A, Michel F, Jirou-Najou J. Study of dose response curves of fenoterol, ipratropium bromide and Berodual. Postgraduate Medical Journal 1987;63(Suppl 1):13. 3129586
93. Cockcroft DW, Killian DN, Mellon JJ, Hargreave FE. Protective effect of drugs on histamine-induced asthma. Thorax 1977;32:429. 3129588
94. Cox ID, Hughes DT, McDonnell KA. Ipratropium bromide in patients with nocturnal asthma. Postgraduate Medical Journal 1984;60:526. 3129590
95. Crane J, Gamble S. Single dose comparison of salbutamol and a fenoterol/ipratropium combination from metered aerosols in patients with asthma. New Zealand Medical Journal 1986;99:420. 3129592
96. Crane J. Single-dose comparison of salbutamol and Duovent-Berodual in asthma. Respiration 1986;50(Suppl 2):285. 3129594
97. Crane J, Town G, O'donnell T. Duovent in obstructive airways disease: comparison with salbutamol by metered aerosol in respect of degree and duration of bronchodilation in. Postgraduate Medical Journal 1987;63(Suppl 1):3. 3129596
98. del Bufalo DC, Fabbri M, Gunella G, Longi R. Effetti sulla funzione ventilatoria dell'associazione fenoterolo-bromuro di ipratropium. Rivista di Patologia e Clinica della Tubercolosi e di Pneumologia 1982;53:637. 3129598
99. Donkers JM, van Schayck CP, Akkermans RP. The difference in bronchodilation effect of a beta two-mimetic and an anticholinergic agent in patients with asthma or chronic obstructive lung. Ned Tijdschr Geneeskd 1998;142:1419. 3129600
100. Donner CF. [IS there a placebo ie beclo plus (IB vs placebo?)] Bronchospasm management by means of ipratropium, beclomethasone and their combination. Giornale Italiano della Tubercolosi e Delle Malattie del Torace 1980;34:307. 3129602
101. Dutt NS, Reddy TC, Raghuveer TS, Yeshwanth M, Sunil Dutt N, Chinnapa Reddy T, et al. A comparative study of atropine sulphate, terbutaline and their combination in asthmatic children. Lung India 1990;8(2):73-5. 3129604
102. Elwood RK, Abboud RT. The short-term bronchodilator effects of fenoterol and ipratropium in asthma. Journal of Allergy and Clinical Immunology 1982;69:467. 3129606
103. Emirgil C, Dwyer K, Baskette P, Sobol BJ. A new parasympatholytic bronchodilator: a study of its onset of effect after inhalation. Current Therapeutic Research 1975;17:215. 3129608
104. Endoh N, Ichinose M, Takahashi T, Miura M, Kageyama N, Mashito Y, et al. Relationship between cholinergic airway tone and serum immunoglobulin E in human subjects. European Respiratory Journal 1998;12:71. 3129610
105. Filiz A, Ekinci E, Dikensoy O, Bulgur D, Oz M. Comparison of a single dose of aerosol salbutamol and fenoterol/ipratropium on bronchial asthmatic patients. Delaware Medical Journal 1994;66:549. 3129612
106. Firstater E, Mizrachi E, Topilsky B. The effect of vagolytic drugs on airway obstruction in patients with bronchial asthma. Annals of Allergy 1981;46:332. 3129614
107. Fischbacher CM, Milroy R, Giannini D, Monie RD. Comparison of Duovent and salbutamol inhalers in chronic stable asthma. Postgraduate Medical Journal 1984;60(Suppl 1):28. 3129616
108. Flint KC, Hockley B, Johnson NM. A comparison between a combination of ipratropium bromide plus fenoterol in a single metered dose inhaler (Duovent) and salbutamol in asthma. Postgraduate Medical Journal 1983;59:724. 3129618
109. Flint K, Hockley B, Johnson NM. Salbutamol versus Duovent (a combination of fenoterol and ipratropium bromide) in asthma. European Journal of Respiratory Diseases-Suppl 1983;128(Pt 2):548. 3129620
110. Flint K, Hockley B, Johnson NM. A comparison between a combination of ipratropium bromide plus fenoterol in a single metered dose inhaler (Duovent) and salbutamol in asthma. Postgraduate Medical Journal 1984;60(Suppl 1):23. 3129622
111. Foster WM, Langenback EG, Glaser ML, Bergofsky EH. Acute effect of ipratropium bromide at therapeutic dose on mucus transport of adult asthmatics. European Journal of Respiratory Diseases-Suppl 1983;128(Pt 2):554. 3129624
112. Freeman W, Javaid A, Cayton RM. The effect of ipratropium bromide on maximal exercise capacity in asthmatic and non-asthmatic men. Respiratory Medicine 1992;86:151. 3129626
113. Frith PA, Atkinson J. Airway anticholinergic effects of oxitropium. Postgraduate Medical Journal 1987;63(Suppl 1):5. 3129628
114. Gaba S, Trigui F, Michel FB, Jirou-Najou JL. Circadian rhythms in asthmatics: comparison of Berotec, Atrovent and Berodual bronchodilating action. Postgraduate Medical Journal 1987;63(Suppl 1):13. 3129630
115. Gillies AJ, Stewart D. A dose response study comparing Duovent with salbutamol. Postgraduate Medical Journal 1987;63(Suppl 1):19. 3129632
116. Ginesu F, Ortu AR, Schena GP, Deiola G, Polo F. Controlled clinical study of the effects of a single aerosol administration of a fenoterol-ipratropium bromide combination in comparison with. Archivio Monaldi Per La Tisiologia e Le Malattie Dell Apparato Respiratorio 1983;38:241. 3129634
117. Gotz RS. Effect of the inhalation of an atropine derivative (ipratropium bromide) in powder form on respiratory mechanics in obstructive airway. Praxis und Klinik der Pneumologie 1983;37(Suppl 1):927. 3129636
118. Grandordy BM, Thomas V, de Lauture D, Marsac J. Cumulative dose-response curves for assessing combined effects of salbutamol and ipratropium bromide in chronic asthma. European Respiratory Journal 1988;1:531. 3129638
119. Gross NJ. Sch 1000: a new anticholinergic bronchodilator. The American Review of Respiratory Disease 1975;112:823. 3129640
120. Gross HJ. Dose-response study of the effect of Sch 1000 MDI on forced vital capacity (FVC), FEV1.0, maximal mid-expiratory flow (MMEF) and heart rate, ECG. Postgraduate Medical Journal 1975;51(Suppl 7):95. 3129642
121. Gross NJ, Skorodin MS. Anticholinergic, antimuscarinic bronchodilators[Review] [243 refs]. The American review of respiratory disease 1984;129:856. 3129644
122. Gross NJ, Bankwala Z. Effects of an anticholinergic bronchodilator on arterial blood gases of hypoxemic patients with chronic obstructive pulmonary disease;. The American review of respiratory disease 1987;136:1091. 3129646
123. Gutersohn. The effect of Raw on Sch1000 MDI or fenoterol MDI and the combined administration of subthreshold dosages of both compounds. Postgraduate Medical Journal 1975;51(Suppl 7):113. 3129648
124. Guyatt G, Sackett D, Taylor DW, Chong J, Roberts R, Pugsley S. Determining optimal therapy Randomized trials in individual patients. New England Journal of Medicine 1986;314:889. 3129650
125. Higgins BG, Powell RM, Cooper S, Tattersfield AE. Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis. European Respiratory Journal 1991;4:415. 3129652
126. Hockley B, Johnson NM. A comparison of three high doses of ipratropium bromide in chronic asthma. British Journal of Diseases of the Chest 1985;79:379. 3129654
127. Hoffstein V, Zamel N, McClean P, Chapman KR. Changes in pulmonary function and cross-sectional area of trachea and bronchi in asthmatics following inhalation of procaterol hydrochloride and. American Journal of Respiratory and Critical Care Medicine 1994;149:81. 3129656
128. Holst PE, Gebbie T, Martin PD, O'Donnell TV. A long term trial of ipratropium in asthmatic patients. Australian and New Zealand Journal of Medicine 1976;11:367. 3129658
129. Huhti E, Poukkula A. Comparison of fenoterol, ipratropium bromide, and their combination in patients with asthma or chronic airflow obstruction. Respiration 1986;50(Suppl 2):298. 3129660
130. Hunt D, MacDonald GF, Reilly P, Plumley D, Kazim F. Bronchodilator response to several doses of ipratropium bromide in asthmatics and bronchitics. Current Therapeutic Research, Clinical and Experimental. 1983;33:651. 3129662
131. Irsigler G. Flow volume curves and changes in FEV1.0, forced vital capacity (FVC), mid and slow vital capacity (Mid VC and SVC) in patients with bronchial. Postgraduate medical journal Suppl 7 1975;51:96. 3129664
132. Jenkins CR, Chow CM, Fisher BL, Marlin GE. Comparison of ipratropium bromide and salbutamol by aerosolized solution. Australian and New Zealand Journal of Medicine 1981;11:513. 3129666
133. Jenkins CR, Chow CM, Fisher BL, Marlin GE. Ipratropium bromide and fenoterol by aerosolized solution. British Journal of Clinical Pharmacology 1982;14:113. 3129668
134. Jindal SK, Kaur SJ. Relative bronchodilatory responsiveness attributable to sympathetic and parasympathetic activity in bronchial asthma. Respiration 1989;56:16. 3129670
135. Johnson MA, Newman SP, Bloom R, Talaee N, Clarke SW. Delivery of albuterol and ipratropium bromide from two nebulizer systems in chronic stable asthma- Efficacy and pulmonary deposition. Chest 1989;96:6. 3129672
136. Jolobe OM, Lane DJ. Atropine responsiveness in asthma in relation to steroid aerosol therapy. British Journal of Diseases of the Chest 1981;75:413. 3129674
137. Kaik G. Untersuchungen mit dem neuen Bronchospamolytikum Ipratropiumbromid (Sch 1000, Atrovent). Therapiewoche 1975;25:2428. 3129676
138. Kaik G. [Whole-body plethysmographic studies on the bronchospasmolytic effect of 2 antiasthmatic drug combinations and ipratropium bromide]. Wiener Medizinische Wochenschrift 1976;126:127. 3129678
139. Kaik G. [Lung function studies with the bronchodilator terbutaline]. Acta medica Austriaca 1979;6:1. 3129680
140. Kamburoff PL, Gunthner W. Dose-dependent effects of Sch 1000 MDI on the airways resistance indices in patients with chronic airways obstruction. Postgraduate Medical Journal 1975;51(Suppl 7):97. 3129682
141. Kaptein AA, Brand PL, Dekker FW, Kerstjens HA, Postma DS, Sluiter HJ. Quality-of-life in a long-term multicentre trial in chronic nonspecific lung disease: Assessment at baseline. European Respiratory Journal 1993;6:1479. 3129684
142. Kennedy MC, Thursby-Pelham DC. Some adrenergic drugs and atropine methonitrate given by inhalation for asthma: a comparative study. BMJ 1964;1:1018. 3129686
143. Kerstjens HA, Brand PL, Hughes MD, Robinson NJ, Postma DS, Sluiter HJ, et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. New England Journal of Medicine 1992;327:1413. 3129688
144. Kerstjens HA, Brand PL, Quanjer PH, van der Bruggen-Bogaarts Koeter GH, Postma DS. Variability of bronchodilator response and effects of inhaled corticosteroid treatment in obstructive airways disease. Dutch CNSLD Study Group. Thorax 1993;48:722. 3129690
145. Kerstjens HA. Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled corticosteroid. European respiratory journal 1993;6:868. 3129692
146. Kerstjens HA, Brand PL, de Jong PM, Koeter GH, Postma DS. Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms. Thorax 1994;49:1109. 3129694
147. Kerstjens HA, Schouten JP, Brand PLP, Schoonbrood DF, Sterk PJ, Postma DS, et al. Importance of total serum IgE for improvement in airways hyperresponsiveness with inhaled corticosteroids in asthma and chronic obstructive. American Journal of Respiratory & Critical Care Medicine 1995;151:360. 3129696
148. Kok-Jensen AA. Combined inhalation of salbutamol and ipratropin in chronic bronchial obstruction [Kombineret inhalation af salbutamol og ipratropin ved kronisk bronkial obstruktion]. Ugeskrift for Laeger 1979;141(30):2039-41. 3129698
149. Kradjan WA, Driesner NK, Abuan TH, Emmick G, Schoene RB. Effect of age on bronchodilator response. Chest 1992;101:1545. 3129700
150. Kreisman H, Cohen C, Ghezzo H, Vickerson F, Frank H, Wolkove N. Combined therapy with ipratropium and theophylline in asthma. Annals of Allergy 1984;52:90. 3129702
151. Krivoy N, Jubarin A, Gaitini L, Rubin A, Alroy G. Combination therapy of ipratropium bromide, terbutaline and slow release theophylline in asthma and chronic airways obstruction. Postgraduate Medical Journal 1987;63(Suppl 1):21. 3129704
152. Kunkel GS. The importance of nervus vagus for bronchial obstruction of allergic and non-allergic origin and the therapeutic consequences. Praxis der Pneumologie 1976;30:459. 3129706
153. Kunkel G, Magnussen H, Bergmann KC, Juergens UR, de Mey C, Freund E, Hinzmann R, Beckers B. Respimat (a new soft mist inhaler) delivering fenoterol plus ipratropium bromide provides equivalent bronchodilation at half the cumulative dose. Respiration 2000;67:306. 3129708
154. Lahdensuo A, Viljanen A, Muittari A. A comparative study on the effect of Sch1000 MDI, salbutamol and placebo MDI in bronchial asthma. Postgraduate Medical Journal 1975;51(Suppl 7):116. 3129710
155. Laitinen LA, Poppius H. Combination of oxitropium bromide and salbutamol in the treatment of asthma with pressurized aerosols. British Journal of Diseases of the Chest 1986;80:179. 3129712
156. Lanser KG, Foldi M, Sill V. The effect of Tropaacidester Sch 1000 on respiratory resistance [Therapie der obstruktiven Atemwegerkrankung mit einem Atropinderivat (Sch 1000)]. Medizinische Klinik 1975;70(9):380-4. 3129714
157. Larsson K. Ipratropium bromide: bronchodilator action and effect on methacholine-induced bronchoconstriction. Journal of Asthma 1987;24:29. 3129716
158. Lavandier M, Bourcereau J, Jirou-Najou J. Comparison of bronchodilating onset of action of Berotec, Atrovent and Berodual. Postgraduate Medical Journal 1987;63(Suppl 1):13. 3129718
159. Lawford P, Palmer KN. A single dose comparison of a combination of fenoterol and ipratropium aerosols in bronchial asthma. Postgraduate Medical Journal 1983;59:28. 3129720
160. Lefcoe NM, Toogood JH, Blennerhassett G, Baskerville J, Paterson NA. The addition of an aerosol anticholinergic to an oral beta agonist plus theophylline in asthma and bronchitis A double-blind single dose study. Chest 1982;82:300. 3129722
161. Lehrer PM, Hochron SM, Isenberg S, Rausch L, Carr R. The Asthma Symptom Profile: a psychophysically based scale for assessment of asthma symptoms. Journal of Psychosomatic Research 1993;37:515. 3129724
162. Lehrer PM, Hochron SM, Rausch L, Carr R. Effects of aerosol ipratropium bromide on cardiac vagal tone. Chest 1994;105:1701. 3129726
163. Li SF, Yao WJ. Combined application of salbutamol and ipratropium bromide in the treatment of bronchial asthma in children. Herald of Medicine 2003;22(2):96-7. 3129728
164. Lichterfeld A. Safety of Atrovent. Scandinavian journal of respiratory diseases Suppl 1979;103:143. 3129730
165. Linehan WD. The effect of Sch1000 and terbutaline given as MDI on ventilatory function in patients with asthma as measured by spirometry. Postgraduate medical journal Suppl 7 1975;51:116. 3129732
166. Maesen F, Buytendijk HJ. Dose- and time-response curves of Sch 1000 MDI and placebo. Differential response in asthmatics and bronchitics as neasured by FEV1.0, vital. Postgraduate Medical Journal 1975;51(Suppl 7):97. 3129734
167. Maesen FP. Comparison of the effects of Sch 1000 MDI and fenoterol MDI in patients with bronchial asthma and chronic bronchitis. Postgraduate Medical Journal 1975;51(Suppl 7):116. 3129736
168. Maesen FP, Smeets JJ, Rubingh G. Vergelijking van het bronchospasmolytisch effect van druk-aerosolen met fenoterol (Berotec) en van een combinatie van fenoterol en een. Tijdschrift voor geneeskunde 1982;7:1184. 3129738
169. Maesen FP, Smeets JJ, Pover GM. Comparison of the effects of a combination inhaler containing salbutamol and atropine methonitrate By comparison with each component given. Tijdschrift voor Therapie Geneesmiddel en Onderzoek 1985;10:1000. 3129740
170. Mann JS, Howarth PH, Holgate ST. Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity. BMJ 1984;289:469. 3129742
171. Marcatili S, Maselli R. Effects of administration of a single dose of iprafen (l puff) compared with those of a single dose of ipratropium bromide (40 mcg ). Archivio Monaldi Per La Tisiologia e Le Malattie Dell Apparato Respiratorio 1984;39:37. 3129744
172. Marin J, Servera E, Verara P. Efficacy devoid of side effects in the combination of an atropine-like bronchodilator and a low dose of a beta2-mimetic. Postgraduate Medical Journal 1987;63(Suppl 1):18. 3129746
173. Marlin GE, Bush DE, Berend N. Comparison of ipratropium bromide and fenoterol in asthma and chronic bronchitis. British Journal of Clinical Pharmacology 1978;6:547. 3129748
174. Marlin GE, Berend N, Harrison AC. Combined cholinergic antagonist and beta 2-adrenoceptor agonist bronchodilator therapy by inhalation. Australian and New Zealand Journal of Medicine 1979;9:511. 3129750
175. Mattila M, Muittari A. The effect of bronchodilator aerosols on the peak expiratory flow rate in asthmatic patients. Acta Medica Scandinavica 1966;180:421. 3129752
176. McIntosh D. A comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solutions assessing dose-response. Pharmatherapeutica 1986;4:416. 3129754
177. McIntosh D. Comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solution assessing dose response and duration of action. Respiration 1986;50(Suppl 2):310-2. 3129756
178. Millar AB, Bush A, Al-Hillawi H, Goldman J, Denison DM. Ipratropium bromide: are patients treated with optimal therapy?. Postgraduate Medical Journal 1990;66:1040. 3129758
179. Minette A, Marcq M. Oxitropium bromide (Ba 253), an advance in the field of anticholinergic bronchodilating treatments Preliminary results. Revue De l Institut d Hygiene Des Mines 1979;34:115. 3129760
180. Minette P, Dubois P, Delwiche JP. Validity of air-helium DVmax measurements in trials of bronchodilators. Bulletin Europeen de Physiopathologie Respiratoire 1985;21:357. 3129762
181. Morrison JF Pearson SB Dean HG. Parasympathetic nervous system in nocturnal asthma. BMJ 1988;296:1427. 3129764
182. Morrison JF, Pearson SB. The effect of the circadian rhythm of vagal activity on bronchomotor tone in asthma. British Journal of Clinical Pharmacology 1989;28:545. 3129766
183. Morrison JF, Pearson S. The parasympathetic nervous system and the diurnal variation of lung mechanics in asthma. Respiratory Medicine 1991;85:285. 3129768
184. Morton O. Response to Duovent of chronic reversible airways obstruction--a controlled trial in general practice. Postgraduate Medical Journal 1984;60(Suppl 1):32. 3129770
185. Muittari A. Atropine methonitrate in bronchial asthma. Annales Medicinae Internae Fenniae 1968;57:193. 3129772
186. Nishi K, Fujimura M, Myou S, Ooka T, Sakamoto S, Saitou M, et al. Comparison of the bronchodilator activities of oxitropium bromide, fenoterol, and their combination in patients with chronic obstructive. Clinical Autonomic Research 1993;3:41. 3129774
187. Nishimura K, Koyama H, Ishihara K, Hasegawa T, Katayama S, Nakashima A, Izumi T. Additive effect of oxitropium bromide in combination with inhaled corticosteroids in the treatment of elderly patients with chronic asthma. Allergology International 1999;48:85. 3129776
188. Nolte D. Double-blind crossover comparison between a beta-adrenergic agent and a new anticholinergic agent by metered dose inhaler. Respiration 1978;36:32. 3129778
189. Osterwalder JJ. Randomized and controlled single case-study - A scientific approach to difficult therapeutic decisions A practical example for use of. Schweizerische Rundschau Fuer Medizin Praxis 1991;80:1168. 3129780
190. Pavia D, Bateman JR, Sheahan NF, Clarke SW. Effect of ipratropium bromide on mucociliary clearance and pulmonary function in reversible airways obstruction. Thorax 1979;34:501. 3129782
191. Peel ET, Anderson G, Cheong B, Broderick N. A comparison of oxitropium bromide and ipratropium bromide in asthma. European Journal of Respiratory Diseases 1984;65:106. 3129784
192. Peerless AG, Rachelefsky GS, Mickey MR, Katz RM, Siegel SC. Bronchodilator characteristics of nebulized metaproterenol sulfate, isoetharine, and atropine in chronic asthma. Journal of Allergy and Clinical Immunology 1983;72:702. 3129786
193. Petrie GR, Palmer KN. Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma. BMJ 1975;1:430. 3129788
194. Petrie GR, Palmer K. Comparative trial of Sch1000 MDI and salbutamol MDI in chronic bronchitis and bronchial asthma. Postgraduate Medical Journal 1975;51(Suppl 7):117. 3129790
195. Petro W. Bronchodilator effect of a combination of a beta-adrenergic agonist and a cholinergic antagonist [Broncholyse unter Kombinierter anwendun]. Praxis und Klinik der Pneumologie 1981;35(1 Spec):779. 3129792
196. Philip-Joet F Herkert A Vervloet D Arnaud A. [Comparative study of anticholinergic and betamimetic agents in the treatment of asthma attacks]. Revue De Pneumologie Clinique 1986;42:292. 3129794
197. Pierce RJ, Allen CJ, Campbell AH. A comparative study of atropine methonitrate, salbutamol, and their combination in airways obstruction. Thorax 1979;34:45. 3129796
198. Pounsford JC, Fuller RW, Saunders KB. A cumulative dose response study of oxitropium bromide (Ba 253) in asthmatics. European Journal of Respiratory Diseases-Supplement 1983;128(Pt 2):536-9. 3129798
199. Pounsford JC. What are the relative places of ipratropium, salmeterol and montelukast in maintenance therapy asthma in the elderly? [ongoing trial]. National Research Register (UK) 2001. [N0234093764]3129800
200. Rafferty P, Howarth P, Mann JS, Holgate S. Bronchoconstriction induced by nebulized ipratropium bromide: relation to the bromide ion. Postgraduate Medical Journal 1987;63(Suppl 1):12. 3129802
201. Rebuck AS, Marcus HI. SCH 1000 in psychogenic asthma. Scandinavian Journal of Respiratory Diseases 1979;103(Suppl):186. 3129804
202. Riding WD, Dinda P, Chatterjee SS. The bronchodilator and cardiac effects of five pressure-packed aerosols in asthma. British Journal of Diseases of the Chest 1970;64:37. 3129806
203. Ruffin RE, Fitzgerald JD, Rebuck AS. A comparison of the bronchodilator activity of Sch 1000 and salbutamol. Journal of Allergy and Clinical Immunology 1977;59:136. 3129808
204. Ruffin RE, Newhouse MT. Ipratropium bromide (Sch 1000) monohydrate aerosol: bronchodilator effect of three dose levels in asthmatics. Lung 1978;155:141. 3129810
205. Ruffin RE, McIntyre E, Crockett AJ, Zielonka K, Alpers JH. Combination bronchodilator therapy in asthma. Journal of Allergy and Clinical Immunology 1982;69:60. 3129812
206. Ruffin RE, Meki M, Alpers JH. Combined bronchodilator protection against histamine-induced bronchoconstriction. Postgraduate Medical Journal 1987;63(Suppl 1):10. 3129814
207. Rutkowski R, Kazberuk M, Siergiejko Z, Chyrek-Borowska S. Effect of fenoterol, ipratropium bromide and combination drug-berodual-on selected clinical parameters and lung function. Pneumonologia i Alergologia Polska 1994;62:358. 3129816
208. Rutten-van-Molken MP, van-Doorslaer EK, Jansen MC, Kerstjens HA, Rutten FF. Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 1995;151:975. 3129818
209. Sahay JN, Bell R, Barber PV, Chatterjee SS, Cox GA. Comparison of ipratropium bromide and salbutamol therapy by inhalation in asthma. British Journal of Diseases of the Chest 1980;75:323. 3129820
210. Sahlstrom K, Alanko K, Harkonen R. Treatment of asthma bronchiale with a combination of ipratropium bromide and fenoterol. Respiration 1986;50(Suppl 2):302. 3129822
211. Salome CM, Wright W, Sedgwick CJ, Woolcock AJ. Acute effects of fenoterol (Berotec) and ipratropium bromide (Atrovent) alone and in combination on bronchial hyperresponsiveness in asthmatic. Progress in Clinical & Biological Research 1988;263:405. 3129824
212. Schindl-R. [Atropine derivatives as dose aerosol in inhalation therapy of bronchial asthma]. Medizinische Welt 1973;24:603. 3129826
213. Schlueter DP, Neumann JL. Double blind comparison of acute bronchial and ventilation-perfusion changes to atrovent and isoproterenol. Chest 1978;73(Suppl 6):982. 3129828
214. Schroeckenstein DC, Bush RK, Chervinsky P, Busse WW. Twelve-hour bronchodilation in asthma with a single aerosol dose of the anticholinergic compound glycopyrrolate. Journal of Allergy and Clinical Immunology 1988;82:115. 3129830
215. Schultze-Werninghaus G. Anticholinergic versus beta 2-adrenergic therapy in allergic airways obstruction: double-blind trials on bronchodilator effect and antiallergic. Respiration 1981;41:239. 3129832
216. Shneerson JM. Comparison of the bronchodilation of ipratropium bromide and fenoterol nebuliser solutions administered alone and in combination. Respiration 1986;50(Suppl 2):274. 3129834
217. Simonsson BG. Acute effects of ipratropium bromide (ITBR, Sch 1000, Atrovent): a review of previous studies. Scandinavian Journal of Respiratory Diseases 1979;103(Suppl):130. 3129836
218. Smith CM, Anderson SD, Seale JP. The duration of action of the combination of fenoterol hydrobromide and ipratropium bromide in protecting against asthma provoked by hyperpnea. Chest 1988;94:709. 3129838
219. Snow RM, Miller WC, Blair HT, Rice DL. Inhaled atropine in asthma. Annals of Allergy 1979;42:286. 3129840
220. Spector S, Ball RE. Bronchodilating effects of aerosolized Sch 1000 and atropine sulfate in asthmatics. Chest 1975;68:426. 3129842
221. Speirs D, Hill L, Kirkbride P. The dose response study to compare Atrovent metered dose inhalers with and without an extension tube. Postgraduate Medical Journal 1987;63(Suppl 1):6. 3129844
222. Stewart DE, Gillies AJ. A dose response study comparing Duovent vs salbutamol. New Zealand Medical Journal 1987;100:742. 3129846
223. Storms WW, DoPico G, Reed C. Aerosol Sch 1000. The American Review of Respiratory Disease 1975;111:419. 3129848
224. Storms WW, Reed CE. Dose-titration study of Sch 1000 MDI in comparison with isoprenaline. Postgraduate Medical Journal 1975;51(Suppl 7):99. 3129850
225. Stresemann E. Time-response curves of Sch 1000 and isoprenaline as metered dose inhalers (MDI) as assessed by measurements of total airways resistance (Rt). Postgraduate Medical Journal 1975;51(Suppl 7):119. 3129852
226. Stresemann E. Time response determinations from analysis of pulmonary function following ipratropiumbromide and isoprenaline. Arzneimittel Forschung 1976;26(5A):1015. 3129854
227. Stresemann-E. Short Communication: Rotation-viscosimetric determinations of the effect of ipratropiumbromide on bronchial excretion/a double blind study. Arzneimittel Forschung 1976;26(5A):1013. 3129856
228. Sur S, Mohiuddin AA, Vichyanond P, Nelson HS. A random double-blind trial of the combination of nebulized atropine methylnitrate and albuterol in nocturnal asthma. Annals of Allergy 1990;65:384. 3129858
229. Tang OT, Flatley M. A comparison of effects of inhaling a combined preparation of fenoterol with ipratropium bromide (Duovent) with those of fenoterol and. Postgraduate Medical Journal 1984;60(Suppl 1):24. 3129860
230. Tarlo SM, Broder I, Corey P. Six-month double-blind cross-over trial comparing an inhaled anticholinergic agent and placebo in the treatment of asthma. Current Therapeutic Research, Clinical and Experimental. 1982;32:265. 3129862
231. Taube C, Kanniess F, Gronke L, Richter K, Mucke M, Paasch K, et al. Reproducibility of forced inspiratory and expiratory volumes after bronchodilation in patients with COPD or asthma. Respiratory Medicine 2002;97:568. 3129864
232. Thiessen B, Pedersen OF. A double blind cross-over study of maximal expiratory flows and arterial blood gas tensions in normals, asthmatics and bronchitics after. Scandinavian Journal of Respiratory Diseases 1979;103(Suppl):170. 3129866
233. Trinquet G, Duchier J, Jacquot C. The bronchodilating effect of Sch 1000 MDI and inhalations of atropine sulphate in patients suffering from bronchial asthma or from chronic. Postgraduate Medical Journal 1975;51(Suppl):119. 3129868
234. Tukiainen P, Salorinne Y. Oxitropium, salbutamol and their combination in asthma. European Journal of Respiratory Diseases 1985;67:31. 3129870
235. Uffholtz H. The effects of Sch 1000 MDI on specific airways resistance in comparison with salbutamol in patients with asthma and chronic bronchitis. Postgraduate Medical Journal 1975;51(Suppl 7):120. 3129872
236. Ullah M, Saunders KB. Influence of age on response to ipratropium bromide and salbutamol in asthmatic patients. Progress in Respiratory Research 1980;14:150. 3129874
237. Ullah MI, Newman GB, Saunders KB. Influence of age on response to ipratropium and salbutamol in asthma. Thorax 1981;36:523. 3129876
238. Ulmer WT. Treatment of obstructive disease with fenoterol-ipratropiumbromid dosage aerosol (IK 6). Short and long-terms results [Die Behandlung obstruktiver Atemwegserkrankungen mit fenoterol-ipratropiumbromidgemisch-Dosieraerosol (IK6)]. Medizinische Klinik 1979;74(42):1548-52. 3129878
239. Vakil DV, Ayiomamitis A, Nizami RM. Use of ipratropium aerosol in the long-term management of asthma. Journal of Asthma 1985;22:165. 3129880
240. Verstraeten JM. [Can the association of an atropinic (SCH 1000) and a sympathicomimetic improve the bronchodilatation obtained by a sympathicomimetic alone]. Acta tuberculosea et pneumologica Belgica 1974;65:395. 3129882
241. Verstraeten JM. [Comparative study of the bronchodilating effect of SCH 1000, berotec and of the association of the two drugs]. Acta tuberculosea et pneumologica Belgica 1974;65:534. 3129884
242. Verstraeten JM. Bronchial response of asthmatic and bronchitic patients to fenoterol MI with or without subsequent Sch 1000 MDI. Postgraduate Medical Journal 1975;51(Suppl 7):120. 3129886
243. Villate Navarro JI, Sobradillo Pena V, Atxotequi Iaraoligoitia V, Salaverri Nalda A, Orive Martinez C. [Comparative effects of terbutaline sulphate and ipratropium bromide on the respiratory system]. Medecine Clinique et Experimentale 1980;74:275. 3129888
244. Vlagopoulos T, Townley R, Ghazanshahi S, Bewtra A, Burke K. Comparison of the onset of action and bronchodilation effects of the anticholinergic agent SCH 1000 with isoproterenol. Journal of Allergy and Clinical Immunology 1975;55:99. 3129890
245. Vlagopoulos T, Townley R, Ghazanshahi S, Bewtra A, Burke K. Comparison of the bronchodilating effects of Sch 1000 with isoproterenol in patients with bronchial asthma. Annals of Allergy 1976;36:223. 3129892
246. Vogt R, Rychel F. Acute test comparing ipratropium bromide (Sch 1000), fenoterol and placebo, by measured dose aerosol, in obstructive lung disease. Therapiewoche 1974;24:4228. 3129894
247. Walker FB, Kaiser DL, Kowal MB, Suratt PM. Prolonged effect of inhaled glycopyrrolate in asthma. Chest 1987;91:49. 3129896
248. Ward MJ, MacFarlane JT, Davies D. Anticholinergics in severe asthma. Postgraduate Medical Journal 1987;63(Suppl 1):2. 3129898
249. Watson A, Lim TK, Joyce H, Pride NB. Failure of inhaled corticosteroids to modify bronchoconstrictor or bronchodilator responsiveness in middle-aged smokers with mild airflow. Chest 1992;101:350. 3129900
250. Wegener T, Hedenstrom H. Effect of nebulized ipratropium bromide on lung function in nonallergic bronchial asthma. Respiration 1987;52:1. 3129902
251. Wegener T, Hedenstrom R. Effect of nebulized ipratropium bromide on lung function in non-allergic bronchial asthma. Postgraduate Medical Journal 1987;63(Suppl 1):6. 3129904
252. Wempe JB, Postma DS, Breederveld N, Alting-Hebing D, van der Mark TW, Koeter GH. Separate and combined effects of corticosteroids and bronchodilators on airflow obstruction and airway hyperresponsiveness in asthma. Journal of Allergy and Clinical Immunology 1992;89:679. 3129906
253. Wesolowski S. [The role of anticholinergic drugs in the treatment of bronchospastic conditions]. Pneumonologia Polska 1985;53:49. 3129908
254. Wildbolz U, Kyd K, Scherrer M. Ipratropium in addition to theophylline-sustained betastimulation. Lung 1977;154:141. 3129910
255. Wilson RH, Battaglia PJ, Wilson NL. Crossover study with nebulized bronchodilators and atropine. Chest 1978;73(Suppl 6):998. 3129912
256. Windom HH, Burgess CD, Siebers RW, Purdie G, Pearce N, Crane J, Beasley R. The pulmonary and extrapulmonary effects of inhaled beta-agonists in patients with asthma. Clinical Pharmacology and Therapeutics 1990;48:296. 3129914
257. Yanai M, Ohrui T, Sekizawa K, Shimizu Y, Sasaki H, Takishima T. Effective site of bronchodilation by antiasthma drugs in subjects with asthma. Journal of Allergy and Clinical Immunology 1991;87:1080. 3129916
258. Yang SC, Wu MC. The response pattern of patients with chronic airway obstruction to bronchodilators. Journal of the Formosan Medical Association of Taiwan 1989;88:700. 3129918
259. Yeager H, Weinberg RM, Kaufman LV, Katz S. Asthma: comparative bronchodilator effects of ipratropium bromide and isoproterenol. Journal of Clinical Pharmacology 1976;16:198. 3129920
260. Zanen P, Go LT, Lammers JW. The optimal particle size for parasympathicolytic aerosols in mild asthmatics. International Journal of Clinical Pharmacology and Therapeutics 1995;114:111. 3129922
261. Zaritsky A, Qureshi F. Ipratropium does indeed reduce admissions to hospital with severe asthma. BMJ 1999;318:738. 3129924
262. Zuck P, Peiffert G, Jirou-Najou JL. Study of fenoterol and ipratropium bromide additive action in asthmatic patients. Postgraduate Medical Journal 1987;63(Suppl 1):14. 3129926
263. Barnes PJ. Pathophysiology of asthma. British Journal of Clinical Pharmacology 1996;42:3-10.
264. Barnes PJ. Current therapies for asthma. Chest 1997;111(Suppl.):17S-26S.
265. Beakes DE. The use of anticholinergics in asthma. Journal of Asthma 1997;34:357-68.
266. Boulet L-P, Becker A, Berube D, Beveridge R, Ernst P. Summary of recommendations from the Canadian Asthma Consensus Report 1999. Canadian Medical Association Journal 1999;161(11 Suppl):S1-S12.
267. Bousquet J. Global initiative for asthma (GINA) and its objectives. Clinical & Experimental Allergy 2000;30(Suppl.1):2-5.
268. British Thoracic Society. Guidelines on the management of asthma. Thorax 1993;48(Suppl.):s1-s24.
269. Scottish Intercollegiate Guidelines Network. Clinical Guidelines. http://www.sign.ac.uk (accessed February 2004).
270. Cazzola M, Centanni S, Donner CF. Anticholinergic agents. Pulmonary Pharmacology & Therapeutics 1998;11:381-92.
271. Clarke M, Oxman AD (editors). Cochrane Reviewers' Handbook 4.2.0 [updated March 2003]. Cochrane Collaboration, 2003.
272. Connolly MJ. Ageing, late-onset asthma and the beta-adrenoceptor. Pharmacology & Therapeutics 1993;60:389-404.
273. Creer TL, Winder JA, Tinkelman D. Guidelines for the diagnosis and management of asthma: accepting the challenge. Journal of Asthma 1999;36:391-407.
274. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31:140-9.
275. Emilien G, Maloteaux J-M. Current therapeutic uses and potential of beta-adrenoceptor antagonists. European Journal of Clinical Pharmacology 1998;53:389-404.
276. Gross NJ. Ipratropium bromide. New England Journal of Medicine 1988;319:486-94.
277. Gross NJ. Anticholinergic drugs. In: Barnes PJ, Grunstein MM editor(s). Asthma. Philadelphia: Lippincott-Raven, 1997:1555-68.
278. Harrison B. Towards evidence-based guidelines for asthma: should we? can we? how will it affect our practice?. Clinical Asthma Reviews 1998;2:139-46.
279. Hougardy DM, Peterson GM, Bleasel MD, Randall CT. Is enough attention being given to the adverse effects of corticosteroid therapy. Journal of Clinical Pharmacology & Therapeutics 2000;25:227-34.
280. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
281. Jolobe OM. Asthma vs. non-specific reversible airflow obstruction: clinical features and responsiveness to anticholinergic drugs. Respiration 1984;45:237-42.
282. Kemp JP. Guidelines Update. Drugs 2000;59(Suppl.1):23-28.
283. Meier CR, Hershel J. Drug use and pulmonary death rates in increasingly symptomatic asthma patients in the UK. Thorax 1997;52:612-7.
284. Ni Chroinin M, Greenstone IR, Danish A, Magdolinos H, Masse V, Zhang X, Ducharme FM. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD005535]
285. O'Connor BJ. Combination therapy. Pulmonary Pharmacology & Therapeutics 1998;11:397-9.
286. Partridge MR, Saunders KB. Site of action of ipratropium bromide and clinical and physiological determinants of response in patients with asthma. Thorax 1981;36:530-3.
287. Spitzer WO, Suissa S, Ernst P, Horwitz R, Habbick B, Cockcroft D, et al. The use of beta-agonists and the risk of death and near death from asthma. New England Journal of Medicine 1992;326:501-6.
288. Taylor DM, Auble TE, Calhoun WJ, Mosesso VN. Current outpatient management of asthma shows poor compliance with international consensus guidelines. Chest 1999;116:1638-45.